975 related articles for article (PubMed ID: 19762090)
1. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
Braam SR; Passier R; Mummery CL
Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
[TBL] [Abstract][Full Text] [Related]
2. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
Murata M; Tohyama S; Fukuda K
Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
[TBL] [Abstract][Full Text] [Related]
3. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
Freund C; Mummery CL
J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
Steel D; Hyllner J; Sartipy P
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
[TBL] [Abstract][Full Text] [Related]
5. Human pluripotent stem cells in drug discovery and predictive toxicology.
Laustriat D; Gide J; Peschanski M
Biochem Soc Trans; 2010 Aug; 38(4):1051-7. PubMed ID: 20659002
[TBL] [Abstract][Full Text] [Related]
6. The application of human embryonic stem cell technologies to drug discovery.
Sartipy P; Björquist P; Strehl R; Hyllner J
Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte differentiation of human induced pluripotent stem cells.
Zwi L; Caspi O; Arbel G; Huber I; Gepstein A; Park IH; Gepstein L
Circulation; 2009 Oct; 120(15):1513-23. PubMed ID: 19786631
[TBL] [Abstract][Full Text] [Related]
8. [Review of basic studies about the cardiac stem cell and regenerative medicine].
Tamura Y; Fukuda K
Nihon Rinsho; 2008 May; 66(5):908-14. PubMed ID: 18464509
[TBL] [Abstract][Full Text] [Related]
9. Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes.
Xu XQ; Sun W
J Cell Biochem; 2013 Jan; 114(1):39-46. PubMed ID: 22903726
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 'stemness' and stem cell differentiation by microRNAs.
Sartipy P; Olsson B; Hyllner J; Synnergren J
IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
12. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
Irion S; Nostro MC; Kattman SJ; Keller GM
Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
[TBL] [Abstract][Full Text] [Related]
13. Generation of cardiomyocytes from new human embryonic stem cell lines derived from poor-quality blastocysts.
Raya A; Rodríguez-Pizà I; Arán B; Consiglio A; Barri PN; Veiga A; Izpisúa Belmonte JC
Cold Spring Harb Symp Quant Biol; 2008; 73():127-35. PubMed ID: 19028986
[TBL] [Abstract][Full Text] [Related]
14. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
Crook JM; Kobayashi NR
J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era.
Yuasa S; Fukuda K
Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):803-10. PubMed ID: 18570618
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
Dambrot C; Passier R; Atsma D; Mummery CL
Biochem J; 2011 Feb; 434(1):25-35. PubMed ID: 21269276
[TBL] [Abstract][Full Text] [Related]
17. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells.
Xu C
J Mol Cell Cardiol; 2012 Jun; 52(6):1203-12. PubMed ID: 22484618
[TBL] [Abstract][Full Text] [Related]
18. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes.
Capi O; Gepstein L
J Control Release; 2006 Nov; 116(2):211-8. PubMed ID: 17005287
[TBL] [Abstract][Full Text] [Related]
19. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
[TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cells: current technologies and emerging industrial applications.
Améen C; Strehl R; Björquist P; Lindahl A; Hyllner J; Sartipy P
Crit Rev Oncol Hematol; 2008 Jan; 65(1):54-80. PubMed ID: 17689256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
